Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ortho sulfonylated arylamine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113929605A reveals a metal-free route to ortho-sulfonylated arylamines via [2,3]-rearrangement, offering significant cost reduction and supply chain stability for pharmaceutical manufacturing.
Patent CN113929605B reveals a metal-free [2,3]-rearrangement for ortho-sulfonylation. Offers mild conditions, high regioselectivity, and cost-effective API intermediate manufacturing.